about
From the Cover: The Minipig is a Suitable Non-Rodent Model in the Safety Assessment of Single Stranded Oligonucleotides.The expanding view of RNA and DNA function.Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER)Spiegelzymes: sequence specific hydrolysis of L-RNA with mirror image hammerhead ribozymes and DNAzymes.EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma.Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance.The distribution, clearance, and safety of an anti-MMP-9 DNAzyme in normal and MMTV-PyMT transgenic mice.Antiangiogenic and antitumoral effects mediated by a vascular endothelial growth factor receptor 1 (VEGFR-1)-targeted DNAzyme.Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity.Inhibition of vein graft stenosis with a c-jun targeting DNAzyme in a cationic liposomal formulation containing 1,2-dioleoyl-3-trimethylammonium propane (DOTAP)/1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE).Overcoming EGFR T790M-based Tyrosine Kinase Inhibitor Resistance with an Allele-specific DNAzyme.DNA enzymes as potential therapeutics: towards clinical application of 10-23 DNAzymes.DNA Catalysis: The Chemical Repertoire of DNAzymes.DNAzyme-based therapeutics for cancer treatment.Fluorescence visualization screening for EBV-LMP1-targeted DNAzymes.Destroying c-jun Messenger: new insights into biological mechanisms of DNAzyme function
P2860
Q33632091-D269A63F-76F5-4267-B74F-118D73802854Q34228096-2407CB8E-537F-4F81-AD9F-E4E9DD48DF6CQ34343851-6B64FF5A-01E8-41F4-853C-8CC7D4F7D7CCQ34575626-ED77ED7E-0010-4547-8CD0-C28B2204D340Q35742407-25895A4E-7650-444E-B09B-0718AF85F7F4Q36902056-137C1A94-8EFC-49E5-BFB6-D4B95CA8373FQ37404297-F437C6D9-B8AB-42BB-9BA6-C9E1948991DDQ37446015-862AEE6C-3A9F-4E0D-ACD5-99145F82EFBCQ37610098-BCC74862-887A-437D-AE88-A7D93879FBB8Q37633665-95E9B5F6-DE96-4665-BB6E-59C59357F35EQ37695540-D7D25EE9-B453-4C32-BC51-E0C44E3FCD88Q38378692-2D4AD010-F11E-4CE3-97F2-B2DA4C6DC41EQ38648771-0DE0C714-73F4-4A2A-B891-C430B91DB790Q38962770-06AD18C4-EC59-4A6E-A870-6B53CAA47150Q39044977-4CB97E71-46B7-4A86-9C79-81BD33539A35Q42325282-C7DC0D92-B854-457C-99A5-368064FC0C8E
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
DNAzyme targeting c-jun suppresses skin cancer growth.
@en
DNAzyme targeting c-jun suppresses skin cancer growth.
@nl
type
label
DNAzyme targeting c-jun suppresses skin cancer growth.
@en
DNAzyme targeting c-jun suppresses skin cancer growth.
@nl
prefLabel
DNAzyme targeting c-jun suppresses skin cancer growth.
@en
DNAzyme targeting c-jun suppresses skin cancer growth.
@nl
P2093
P2860
P50
P1476
DNAzyme targeting c-jun suppresses skin cancer growth
@en
P2093
Beng H Chong
Christopher R Parish
Colin N Chesterman
Douglas J Francis
Fergal J Moloney
Fernando S Santiago
Gary M Halliday
Ghassan J Maghzal
P2860
P304
P356
10.1126/SCITRANSLMED.3003960
P407
P577
2012-06-01T00:00:00Z